Carlos R. Garcia-Batres
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Carlos R. Garcia-Batres has a total of 46 co-authors. Here are the top co-authors by number of shared publications:
- Pamela S. Ohashi
Department of Immunology, University of Toronto, Toronto, ON M5S 1A8, Canada
40 shared publications - Douglas C. Chung
Department of Immunology, University of Toronto, Toronto, Canada
39 shared publications - Linh T. Nguyen
Princess Margaret Cancer Centre, Toronto, ON M5G 2C1, Canada
39 shared publications - Marcus Q. Bernardini
University of Toronto, Toronto, Ontario
39 shared publications - Sarah Q. Crome
Department of Immunology, Temerty Faculty of Medicine, University of Toronto, Toronto, Canada
39 shared publications - Alisha R. Elford
Tumour Immunotherapy Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada
38 shared publications
Latest Publications
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S4 from CD103+CD56+ ILCs Are Associated with an Altered CD8+ T-cell Profile within the Tumor Microenvironment
Fig S4. CD101 and GITR expression is expressed on CD103+CD49a+CD56+Lin- ILCs but not other NK cell subsets.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S4 from CD103+CD56+ ILCs Are Associated with an Altered CD8+ T-cell Profile within the Tumor Microenvironment
Fig S4. CD101 and GITR expression is expressed on CD103+CD49a+CD56+Lin- ILCs but not other NK cell subsets.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S7 from CD103+CD56+ ILCs Are Associated with an Altered CD8+ T-cell Profile within the Tumor Microenvironment
Fig. S7. Intratumoural CD103+CD56+Lin- ILCs displayed unique profile of transcription factors.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S7 from CD103+CD56+ ILCs Are Associated with an Altered CD8+ T-cell Profile within the Tumor Microenvironment
Fig. S7. Intratumoural CD103+CD56+Lin- ILCs displayed unique profile of transcription factors.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S5 from CD103+CD56+ ILCs Are Associated with an Altered CD8+ T-cell Profile within the Tumor Microenvironment
Fig. S5. Identifying cellular clusters from scRNA-seq of ovarian tumours.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S5 from CD103+CD56+ ILCs Are Associated with an Altered CD8+ T-cell Profile within the Tumor Microenvironment
Fig. S5. Identifying cellular clusters from scRNA-seq of ovarian tumours.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S10 from CD103+CD56+ ILCs Are Associated with an Altered CD8+ T-cell Profile within the Tumor Microenvironment
Fig. S10. CD103+Lin- ILC1-like cells are associated with altered immune landscape within the TME.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S10 from CD103+CD56+ ILCs Are Associated with an Altered CD8+ T-cell Profile within the Tumor Microenvironment
Fig. S10. CD103+Lin- ILC1-like cells are associated with altered immune landscape within the TME.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S6 from CD103+CD56+ ILCs Are Associated with an Altered CD8+ T-cell Profile within the Tumor Microenvironment
Fig. S6. CD103+CD56+ ILCs have distinct transcriptional networks revealed by SCENIC analysis.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S6 from CD103+CD56+ ILCs Are Associated with an Altered CD8+ T-cell Profile within the Tumor Microenvironment
Fig. S6. CD103+CD56+ ILCs have distinct transcriptional networks revealed by SCENIC analysis.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S5 from CD103+CD56+ ILCs Are Associated with an Altered CD8+ T-cell Profile within the Tumor Microenvironment
Proportion of cells per clusters for each patient sample from scRNA-seq and CITE-seq datasets.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S5 from CD103+CD56+ ILCs Are Associated with an Altered CD8+ T-cell Profile within the Tumor Microenvironment
Proportion of cells per clusters for each patient sample from scRNA-seq and CITE-seq datasets.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S1 from CD103+CD56+ ILCs Are Associated with an Altered CD8+ T-cell Profile within the Tumor Microenvironment
Fig. S1. Gating strategy for intratumoural ILCs.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S1 from CD103+CD56+ ILCs Are Associated with an Altered CD8+ T-cell Profile within the Tumor Microenvironment
Fig. S1. Gating strategy for intratumoural ILCs.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S3 from CD103+CD56+ ILCs Are Associated with an Altered CD8+ T-cell Profile within the Tumor Microenvironment
Fig. S3. CD103+CD56+Lin- ILCs exhibit features that are associated with Tregs.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S3 from CD103+CD56+ ILCs Are Associated with an Altered CD8+ T-cell Profile within the Tumor Microenvironment
Fig. S3. CD103+CD56+Lin- ILCs exhibit features that are associated with Tregs.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S9 from CD103+CD56+ ILCs Are Associated with an Altered CD8+ T-cell Profile within the Tumor Microenvironment
Fig. S9. CD103+CD56+Lin- ILCs express distinct signatures compared to other ILC subsets.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S9 from CD103+CD56+ ILCs Are Associated with an Altered CD8+ T-cell Profile within the Tumor Microenvironment
Fig. S9. CD103+CD56+Lin- ILCs express distinct signatures compared to other ILC subsets.